Therapy Areas: Devices
Medable sets up new EMEA HQ in Dublin to support clinical trial deployments in Europe
15 July 2021 -

Drug company Medable Inc on Wednesday inaugurated its EMEA headquarters in Dublin under the first stage of its European expansion plans.

Based in Dublin, Ireland, the company's new regional headquarters will serve as a European hub for expanded sales, customer success, software development in Europe as well as to help pharma and biotech leaders drive broad adoption of digital clinical trials at global scale. It intends to hire up to 50 positions in Dublin over the next three years under its extensive growth across Europe in coming years.

Through the launch of its European HQ, the company will enable greater engagement with pharma, biotech and medical device companies across the UK, Germany, Switzerland, Spain and Benelux. It has an existing presence in Europe with roughly 60 employees and contractors currently based in the UK, Germany, Denmark and various other locations in Central and Eastern Europe.

The company's software-as-a-service (SaaS) platform has been deployed in more than 60 countries via more than 150 decentralized and hybrid clinical trials. Its customers have achieved unprecedented results – including 3X faster enrolment, 90% retention rates and 50% cost reductions by minimizing the need for in-person site visits.